PATENT CLAIM ANALYSIS

Application Number: 16257770
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["435", "007920"]

Abstract:
The present invention is directed to a method of identifying a patient having heart failure as likely to respond to a therapy comprising a statin. The method is based on measuring the level of at least one marker selected from GDF-15 (Growth Differentiation Factor 15), Urea, SHBG (Sex Hormone-Binding Globulin), Uric acid, PLGF (Placental Growth Factor), IL-6 (Interleukin-6), Transferrin, a cardiac Troponin, sFlt-1 (Soluble fms-like tyrosine kinase-1), Prealbumin, Ferritin, Osteopontin, sST2 (soluble ST2), and hsCRP (high sensitivity C-reactive protein) in a sample from a patient. Further envisaged is a method of predicting the risk of a patient to suffer from death or hospitalization, wherein said patient has heart failure and undergoes a therapy comprising a statin. The method is also based on the measurement of the level of at least one of the aforementioned markers.

Claim (Index 10):
The method of  claim 1  wherein the subject has heart failure classified as stage B or C according to the ACC/AHA classification

Metadata:
- Claim Count in Document: 26.0
- Percentile: 99.0
- Lexical Diversity: 1.8764
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15054255', '15220555', '15581587', '15274533', '13552533']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6263437542966602
- 35 USC 102 Novelty (BERT): 0.5508530891129699
- Combined Prediction Score: 0.6187946877782913
- Mean Citation Score: 267.026296
- Max Citation Score: 408.80835
- Similarity Product: 366.47224228905736

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test